Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma

被引:21
作者
Einsele, H. [1 ]
Knop, S. [1 ]
Vogel, M. [2 ]
Mueller, J. [3 ]
Kropff, M. [4 ]
Metzner, B. [5 ]
Langer, C. [6 ]
Sayer, H. [7 ]
Jung, W. [8 ]
Duerk, H. A. [9 ]
Salwender, H. [10 ]
Wandt, H. [11 ]
Bassermann, F. [12 ]
Gramatzki, M. [13 ]
Roesler, W. [14 ]
Wolf, H-H [15 ]
Brugger, W. [16 ]
Engelhardt, M. [17 ]
Fischer, T. [18 ]
Liebisch, P. [6 ]
Straka, C. [19 ]
机构
[1] Julius Maximilians Univ Wurzburg, Med Klin & Poliklin 2, Wurzburg, Germany
[2] Janssen Cilag GmbH, Neuss, Germany
[3] Acromion GmbH, Frechen, Germany
[4] Univ Klinikum Munster, Munster, Germany
[5] Klinikum Oldenburg Klin Onkol & Hamatol, Oldenburg, Germany
[6] Univ Klinikum Ulm, Zentrum Innere Med, Ulm, Germany
[7] Univ Hosp Jena, Jena, Germany
[8] Onkol Univ Med Gottingen, Gottingen, Germany
[9] St Marien Hosp Hamm Knappenstr, Hamm, Germany
[10] Asklepios Klin Altona, Hamburg, Germany
[11] Med Klin 5 Hamatol & Onkol, Nurnberg, Germany
[12] Tech Univ Munich, Med Klin, Munich, Germany
[13] Univ Klinikum Schleswig Holstein, Kiel, Germany
[14] Univ Klinkum Erlangen, Erlangen, Germany
[15] Univ Hosp Halle, Halle, Saale, Germany
[16] Schwarzwald Baar Klinikum, Villingen Schwenningen, Germany
[17] Univ Freiburg, Freiburg, Germany
[18] Otto von Guericke Univ, Magdeburg, Germany
[19] Schon Klin Starnberger See, Berg, Germany
关键词
STEM-CELL TRANSPLANTATION; INDUCTION; THERAPY; PHASE-3;
D O I
10.1038/leu.2017.83
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1463 / 1466
页数:5
相关论文
共 11 条
[1]   Impact of high-risk cytogenetics and prior therapy on outcomes in patients with advanced relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone [J].
Avet-Loiseau, H. ;
Soulier, J. ;
Fermand, J-P ;
Yakoub-Agha, I. ;
Attal, M. ;
Hulin, C. ;
Garderet, L. ;
Belhadj, K. ;
Dorvaux, V. ;
Minvielle, S. ;
Moreau, P. .
LEUKEMIA, 2010, 24 (03) :623-628
[2]  
Blade Joan, 1998, British Journal of Haematology, V102, P1115, DOI 10.1046/j.1365-2141.1998.00930.x
[3]   Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma [J].
Cavo, Michele ;
Pantani, Lucia ;
Petrucci, Maria Teresa ;
Patriarca, Francesca ;
Zamagni, Elena ;
Donnarumma, Daniela ;
Crippa, Claudia ;
Boccadoro, Mario ;
Perrone, Giulia ;
Falcone, Antonietta ;
Nozzoli, Chiara ;
Zambello, Renato ;
Masini, Luciano ;
Furlan, Anna ;
Brioli, Annamaria ;
Derudas, Daniele ;
Ballanti, Stelvio ;
Dessanti, Maria Laura ;
De Stefano, Valerio ;
Carella, Angelo Michele ;
Marcatti, Magda ;
Nozza, Andrea ;
Ferrara, Felicetto ;
Callea, Vincenzo ;
Califano, Catello ;
Pezzi, Annalisa ;
Baraldi, Anna ;
Grasso, Mariella ;
Musto, Pellegrino ;
Palumbo, Antonio .
BLOOD, 2012, 120 (01) :9-19
[4]   International uniform response criteria for multiple myeloma [J].
Durie, B. G. M. ;
Harousseau, J-L ;
Miguel, J. S. ;
Blade, J. ;
Barlogie, B. ;
Anderson, K. ;
Gertz, M. ;
Dimopoulos, M. ;
Westin, J. ;
Sonneveld, P. ;
Ludwig, H. ;
Gahrton, G. ;
Beksac, M. ;
Crowley, J. ;
Belch, A. ;
Boccadaro, M. ;
Turesson, I. ;
Joshua, D. ;
Vesole, D. ;
Kyle, R. ;
Alexanian, R. ;
Tricot, G. ;
Attal, M. ;
Merlini, G. ;
Powles, R. ;
Richardson, P. ;
Shimizu, K. ;
Tosi, P. ;
Morgan, G. ;
Rajkumar, S. V. .
LEUKEMIA, 2006, 20 (09) :1467-1473
[5]   Consolidation with VTd significantly improves the complete remission rate and time to progression following VTd induction and single autologous stem cell transplantation in multiple myeloma [J].
Leleu, X. ;
Fouquet, G. ;
Hebraud, B. ;
Roussel, M. ;
Caillot, D. ;
Chretien, M. L. ;
Arnulf, B. ;
Szalat, R. ;
Garderet, L. ;
Benajiba, L. ;
Pegourie, B. ;
Regny, C. ;
Royer, B. ;
Caulier, A. ;
Stoppa, A. M. ;
Garciaz, S. ;
Touzeau, C. ;
Chaleteix, C. ;
Fermand, J. P. ;
Loiseau, H. A. ;
Facon, T. ;
Attal, M. ;
Moreau, P. .
LEUKEMIA, 2013, 27 (11) :2242-2244
[6]   International Myeloma Working Group recommendations for global myeloma care [J].
Ludwig, H. ;
Miguel, J. S. ;
Dimopoulos, M. A. ;
Palumbo, A. ;
Garcia Sanz, R. ;
Powles, R. ;
Lentzsch, S. ;
Chen, W. Ming ;
Hou, J. ;
Jurczyszyn, A. ;
Romeril, K. ;
Hajek, R. ;
Terpos, E. ;
Shimizu, K. ;
Joshua, D. ;
Hungria, V. ;
Rodriguez Morales, A. ;
Ben-Yehuda, D. ;
Sondergeld, P. ;
Zamagni, E. ;
Durie, B. .
LEUKEMIA, 2014, 28 (05) :981-992
[7]   Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial [J].
Mellqvist, Ulf-Henrik ;
Gimsing, Peter ;
Hjertner, Oyvind ;
Lenhoff, Stig ;
Laane, Edward ;
Remes, Kari ;
Steingrimsdottir, Hlif ;
Abildgaard, Niels ;
Ahlberg, Lucia ;
Blimark, Cecilie ;
Dahl, Inger Marie ;
Forsberg, Karin ;
Gedde-Dahl, Tobias ;
Gregersen, Henrik ;
Gruber, Astrid ;
Guldbrandsen, Nina ;
Haukas, Einar ;
Carlson, Kristina ;
Kvam, Ann Kristin ;
Nahi, Hareth ;
Lindas, Roald ;
Andersen, Niels Frost ;
Turesson, Ingemar ;
Waage, Anders ;
Westin, Jan .
BLOOD, 2013, 121 (23) :4647-4654
[8]   Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study [J].
Moreau, Philippe ;
Pylypenko, Halyna ;
Grosicki, Sebastian ;
Karamanesht, Ievgenii ;
Leleu, Xavier ;
Grishunina, Maria ;
Rekhtman, Grigoriy ;
Masliak, Zvenyslava ;
Robak, Tadeusz ;
Shubina, Anna ;
Arnulf, Bertrand ;
Kropff, Martin ;
Cavet, James ;
Esseltine, Dixie-Lee ;
Feng, Huaibao ;
Girgis, Suzette ;
van de Velde, Helgi ;
Deraedt, William ;
Harousseau, Jean-Luc .
LANCET ONCOLOGY, 2011, 12 (05) :431-440
[9]   Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p [J].
Neben, Kai ;
Lokhorst, Henk M. ;
Jauch, Anna ;
Bertsch, Uta ;
Hielscher, Thomas ;
van der Holt, Bronno ;
Salwender, Hans ;
Blau, Igor W. ;
Weisel, Katja ;
Pfreundschuh, Michael ;
Scheid, Christof ;
Duehrsen, Ulrich ;
Lindemann, Walter ;
Schmidt-Wolf, Ingo G. H. ;
Peter, Norma ;
Teschendorf, Christian ;
Martin, Hans ;
Haenel, Mathias ;
Derigs, Hans G. ;
Raab, Marc S. ;
Ho, Anthony D. ;
van de Velde, Helgi ;
Hose, Dirk ;
Sonneveld, Pieter ;
Goldschmidt, Hartmut .
BLOOD, 2012, 119 (04) :940-948
[10]   Multiple myeloma: 2014 Update on diagnosis, risk-stratification, and management [J].
Rajkumar, S. Vincent .
AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (10) :999-1009